Literature DB >> 8418182

Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis.

R S Wallis1, M Vjecha, M Amir-Tahmasseb, A Okwera, F Byekwaso, S Nyole, S Kabengera, R D Mugerwa, J J Ellner.   

Abstract

Tuberculosis results in activation of T cells and macrophages that may harbor latent human immunodeficiency virus (HIV-1). Although such activation is beneficial to the host in terms of mycobacterial disease, it may be deleterious in terms of HIV-1. In Ugandan HIV-1-seropositive patients with pulmonary tuberculosis, antigen-induced blastogenesis and production of tumor necrosis factor-alpha (a cytokine that induces expression of HIV-1 in latently infected cells) were 3-10 times greater than in controls. The mean serum beta 2-microglobulin level was 5.22 mg/L in recently diagnosed patients, significantly greater than levels in HIV-negative patients with tuberculosis or asymptomatic HIV-1-seropositive subjects. beta 2-microglobulin was significantly lower in subjects who had completed at least 2 months of antituberculous therapy. These observations suggest that HIV-1-associated tuberculosis is accompanied by immune activation that may result in increased HIV expression and accelerated progression to AIDS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418182     DOI: 10.1093/infdis/167.1.43

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

Review 1.  Antituberculosis treatment: increasing evidence for drug effects on innate cellular immunity.

Authors:  C T Tiemessen; S Shalekoff; S Meddows-Taylor; D J Martin
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

2.  Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda.

Authors:  Harriet Mayanja-Kizza; Edward Jones-Lopez; Alphonse Okwera; Robert S Wallis; Jerrold J Ellner; Roy D Mugerwa; Christopher C Whalen
Journal:  J Infect Dis       Date:  2005-02-08       Impact factor: 5.226

3.  Monocytes modulate enhancement of HIV-1 replication by Mycobacterium tuberculosis.

Authors:  C J De Haas; N M de Vos; M R Visser; H Snippe; J Verhoef
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

4.  Interactions between opportunistic micro-organisms and HIV in the lung.

Authors:  J R Clarke; D Israel-Biet
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

5.  Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease.

Authors:  D V Havlir; F J Torriani; R D Schrier; J Y Huang; M M Lederman; K A Chervenak; W H Boom
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

6.  Distribution of the human immunodeficiency virus coreceptors CXCR4 and CCR5 on leukocytes of persons with human immunodeficiency virus type 1 infection and pulmonary tuberculosis: implications for pathogenesis.

Authors:  S Shalekoff; S Pendle; D Johnson; D J Martin; C T Tiemessen
Journal:  J Clin Immunol       Date:  2001-11       Impact factor: 8.317

7.  HIV co-infection with tuberculous and non-tuberculous mycobacteria in western Kenya: challenges in the diagnosis and management.

Authors:  H D N Nyamogoba; G Mbuthia; S Mining; G Kikuvi; R Biegon; S Mpoke; D Menya; P G Waiyaki
Journal:  Afr Health Sci       Date:  2012-09       Impact factor: 0.927

8.  Mycobacterium avium infection in HIV-1-infected subjects increases monokine secretion and is associated with enhanced viral load and diminished immune response to viral antigens.

Authors:  M Denis; E Ghadirian
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

9.  Clinical research, prophylaxis, therapy, and care for HIV disease in Africa.

Authors:  K M De Cock; S B Lucas; S Lucas; J Agness; A Kadio; H D Gayle
Journal:  Am J Public Health       Date:  1993-10       Impact factor: 9.308

Review 10.  Tuberculosis at the end of the twentieth century.

Authors:  K A Sepkowitz; J Raffalli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.